Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

This pharma stock offers an attractive risk-reward says RBC

Published 10/02/2024, 07:33 AM
© Reuters
TNDM
-

Investing.com -- RBC Capital initiated coverage of Tandem Diabetes Care (NASDAQ:TNDM) with an Outperform rating in a note Wednesday, highlighting the stock’s attractive risk-reward profile.

According to RBC, which set a $65 price target on the stock, Tandem has "significant upside potential" driven by key growth catalysts such as increased adoption of its Mobi insulin pump, integration with continuous glucose monitors (CGMs), and expansion into the Type 2 diabetes market.

RBC Capital believes that TNDM’s growth will be fueled by several factors, including U.S. Mobi adoption, which will drive new patient additions, and a significant renewal opportunity, with over 90,000 pump warranties expiring in 2024.

Additionally, they believe the integration of CGMs like the Libre 3 in 2025, and the expansion into the Type 2 diabetes market, which has 2.5 million potential patients, will further boost revenue.

Despite the growing popularity of GLP-1 therapies, RBC Capital does not believe they pose a threat to Tandem’s growth.

The bank explains that GLP-1s do not reverse the beta cell loss in Type 1 diabetes, and while they can slow the progression of Type 2 diabetes, pumps still play a critical role in glycemic control.

"GLP-1 popularity could even aid earlier Type 2 diagnosis, and insulin intervention, expanding the market," says RBC.

The bank sees room for multiple expansion, with Tandem trading at a discount compared to historical averages. With a potential upside of 58%, RBC believes that TNDM’s earnings growth and increasing profitability make it an attractive investment opportunity.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.